Contact
Score Calculators
Publications
Advancing knowledge in chronic liver disease through evidence-based research.
AbstractsPublication policy

Showing 10 of 274 papers

Quantification of liver fibrosis at T1 and T2 mapping with extracellular volume fraction MRI: Preclinical results

Luetkens JA, Klein S, Träber F, Schmeel FC, Sprinkart AM, Kuetting DLR, Block W, Uschner FE, Schierwagen R, Hittatiya K, Kristiansen G, Gieseke J, Schild HH, Trebicka J, Kukuk GM.

Radiology 2018, 288(3): 748–754

DOI: 10.1148/radiol.2018180051

Acute-on-chronic liver failure

Lange CM, Bechstein WO, Berg T, Engelmann C, Bruns T, Canbay A, Moreau R, Trebicka J.

Visc Med 2018, 34(4): 296–300

DOI: 10.1159/000491406

EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis

European Association for the Study of the Liver

J Hepatol 2018, 69(2): 406–460

DOI: 10.1016/j.jhep.2018.03.024

Gut–liver axis links portal hypertension to acute-on-chronic liver failure

Trebicka J, Reiberger T, Laleman W.

Visc Med 2018, 34(4): 270–275

DOI: 10.1159/000490262

Non-cirrhotic portal hypertension: A possibly benign but complicated disease

Trebicka J. 

Dig Liver Dis 2018, 50(8): 845–846

DOI: 10.1016/j.dld.2018.05.018

The prognostic value of acute-on-chronic liver failure during the course of severe alcoholic hepatitis

Sersté T, Cornillie A, Njimi H, Pavesi M, Arroyo V, Putignano A, Weichselbaum L, Deltenre P, Degré D, Trépo E, Moreno C, Gustot T.

J Hepatol 2018, 69(2): 318–324

DOI: 10.1016/j.jhep.2018.02.022

Systemic inflammation and acute-on-chronic liver failure: Too much, not enough

Laleman W, Claria J, Van der Merwe S, Moreau R, Trebicka J.

Can J Gastroenterol Hepatol 2018, 2018: 1027152

DOI: 10.1155/2018/1027152

Covered transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension: Looking for the right patient and the right time

Senzolo M, Thabut D, Trebicka J.

EMJ Hepatol 2018, 6(Suppl 2): 2 –11

DOI: 10.33590/emjhepatol/10311962

The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic rats

Schwabl P, Brusilovskaya K, Supper P, Bauer D, Königshofer P, Riedl F, Hayden H, Fuchs CD, Stift J, Oberhuber G, Aschauer S, Bonderman D, Gnad T, Pfeifer A, Uschner FE, Trebicka J, Rohr-Udilova N, Podesser BK, Peck-Radosavljevic M, Trauner M, Reiberger T.

Sci Rep 2018, 8(1): 9372

DOI: 10.1038/s41598-018-27656-y

The use of human albumin in patients with cirrhosis: A European survey

Caraceni P, Pavesi M, Baldassarre M, Bernardi M, Arroyo V.

Expert Rev Gastroenterol Hepatol 2018, 12(6): 625–632

DOI: 10.1080/17474124.2018.1460203

Registered office

European Foundation for the Study of
Chronic Liver Failure
Avinguda Diagonal 477, 11th floor
08036 Barcelona, Spain

Legal

Contact us

Tel: +34 93 227 14 00
Email: Send us an email

© European Foundation for the Study of Chronic Liver Failure 2024